INCREASED EXPRESSION OF MUC18 CORRELATES WITH THE METASTATIC PROGRESSION OF MOUSE PROSTATE ADENOCARCINOMA IN THE TRAMP MODEL-Reference-Cited by-同舟云学术

INCREASED EXPRESSION OF MUC18 CORRELATES WITH THE METASTATIC PROGRESSION OF MOUSE PROSTATE ADENOCARCINOMA IN THE TRAMP MODEL

Published:2005-05 Issue:5 Volume:173 Page:1778-1783
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

WU GUANG-JER¹,FU PINGPING¹,CHIANG CHENG-FENG¹,HUSS WENDY J.¹,GREENBERG NORMAN M.¹,WU MEI-WHEY H.¹

Affiliation:

1. From the Department of Microbiology and Immunology, Emory University School of Medicine (G-JW, PF, CC, M-WHW), Atlanta, Georgia, Department of Pathology and Laboratory Medicine, University of North Carolina (WJH), Chapel Hill, North Carolina, and Clinical Research Division, Fred Hutchinson Cancer Research Center (NMG), Seattle, Washington

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference21 articles.

1. Identification of bone marrow micrometastases in patients with prostate cancer

2. Expression of a human cell adhesion molecule, MUC18, in prostate cancer cell lines and tissues

3. Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Netrin-1-CD146 and netrin-1-S100A9 are associated with early stage of lymph node metastasis in colorectal cancer;BMC Gastroenterology;2024-09-11

2. METCAM Is a Potential Biomarker for Predicting the Malignant Propensity of and as a Therapeutic Target for Prostate Cancer;Biomedicines;2023-01-13

3. METCAM/MUC18 Plays a Tumor Suppressor Role in the Development of Nasopharyngeal Carcinoma Type I;International Journal of Molecular Sciences;2022-11-02

4. Soluble CD146 as a Potential Target for Preventing Triple Negative Breast Cancer MDA-MB-231 Cell Growth and Dissemination;International Journal of Molecular Sciences;2022-01-17

5. Validating METCAM/MUC18 as a Novel Biomarker to Predict the Malignant Potential of Prostate Cancer at an Early Stage by Using a Modified Gold Nanoparticles-Based Lateral Flow Immunoassay;Diagnostics;2021-03-04